| Literature DB >> 33999015 |
Deborah L Jones1, Kristiana E Morgan2, Paola C Martinez2, Violeta J Rodriguez1,3, Andres Vazquez1, Patricia D Raccamarich4, Maria L Alcaide4.
Abstract
BACKGROUND: This study evaluated COVID-19 risk and burden among people with HIV (PWH) in a US city with high rates of HIV and SARS-CoV-2 transmissions and examined the interrelationship between psychosocial factors and COVID-19 risk and burden.Entities:
Mesh:
Year: 2021 PMID: 33999015 PMCID: PMC8136457 DOI: 10.1097/QAI.0000000000002656
Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN: 1525-4135 Impact factor: 3.771
Demographic Characteristics (N = 200)
| M (SD) | |
| Age | 53.56 (10.86) |
| Sex | |
| Male | 87 (43.5) |
| Female | 113 (56.5) |
| Born in the United States | 132 (66.0) |
| Race | |
| Black/African American | 140 (70.0) |
| White | 47 (23.5) |
| Asian | 1 (0.5) |
| Native American | 3 (1.5) |
| Other | 9 (4.5) |
| Employed | 40 (20.0) |
| Average monthly income | |
| $500 or less | 37 (18.5) |
| $501–$1000 | 95 (47.5) |
| $1001–$1500 | 24 (12.0) |
| $1501–$2000 | 17 (8.5) |
| $2001–$2500 | 9 (4.5) |
| $2501–$3000 | 5 (2.5) |
| $3001–$6250 | 12 (6.0) |
| Living/housing situation | |
| Own house/apartment | 153 (76.5) |
| Parents' house | 13 (6.5) |
| Someone else's house | 29 (14.5) |
| Rooming, boarding, or halfway house | 4 (2.0) |
| On the street(s) | 1 (0.5) |
COVID-19 burden was calculated as the sum score of participants providing a “yes” response to the items above. Similarly, COVID-19 risk was calculated as the sum score of participants providing a “yes” response to the items above.
COVID-19 Burden and Risk (N = 200)
| N (%) | |
| COVID-19 burden | |
| Test positive for COVID-19 | 7 (3.5) |
| COVID-19 symptoms | 11 (5.5) |
| Suspect COVID-19 infection | 7 (3.5) |
| COVID-19 impact | 93 (46.5) |
| Employment loss due to COVID-19 | 82 (41.0) |
| Childcare loss | 23 (11.5) |
| Financial loss | 17 (8.5) |
| Housing loss | 16 (8.0) |
| Unable to obtain medications | 19 (9.5) |
| Unable to obtain HIV medications | 15 (7.5) |
| Unable to afford medical care | 31 (15.5) |
| Health insurance loss | 9 (4.5) |
| Mental health treatment loss | 23 (11.5) |
| Substance use treatment loss | 25 (12.5) |
| COVID-19 risk | |
| Hypertension | 103 (51.5) |
| Heart disease (eg, cardiomyopathy and coronary artery disease) | 20 (10.0) |
| Diabetes | 43 (21.5) |
| Renal disease | 7 (3.5) |
| Pulmonary disease | 39 (19.5) |
| Neurological conditions | 21 (10.5) |
| Gastrointestinal conditions | 9 (4.5) |
| Cancer | 15 (7.5) |
| History of transplant | 3 (1.5) |
| Rheumatological disease | 22 (11.0) |
| Pneumonia | 12 (6.0) |
| Former tobacco smoker | 21 (10.5) |
| Current tobacco smoker | 11 (5.5) |
COVID-19 burden was calculated as the sum score of participants providing a “yes” response to the items above. Similarly, COVID-19 risk was calculated as the sum score of participants providing a “yes” response to the items above.
Model 1: History of Trauma, Childhood and Adult Physical and Sexual Abuse, PTSD Symptoms, Loneliness, and Stress Predicting COVID-19 Burden and Risk
| β | SE | |||
| Outcome: COVID-19 risk | ||||
| Childhood and adult physical and sexual abuse | 0.023 | 0.081 | 0.28 | 0.778 |
| Posttraumatic stress disorder symptoms | −0.043 | 0.080 | −0.54 | 0.592 |
| Loneliness | 0.128 | 0.080 | 1.61 | 0.108 |
| Stress | 0.169 | 0.080 | 2.12 | 0.035 |
| History of trauma/traumatic events | 0.230 | 0.081 | 2.85 | 0.004 |
| Outcome: COVID-19 burden | ||||
| Childhood and adult physical and sexual abuse | 0.048 | 0.076 | 0.63 | 0.528 |
| Posttraumatic stress disorder symptoms | 0.082 | 0.078 | 1.05 | 0.295 |
| Loneliness | −0.045 | 0.082 | −0.55 | 0.580 |
| Stress | 0.282 | 0.081 | 3.51 | <0.001 |
Standardized coefficients are presented. Model 2 was based off Model 1.
Model 3: COVID-19 Burden and COVID-19 Risk Predicting Depressive Symptoms, Sleep Problems, and Substance Use
| β | SE | |||
| Outcome: depressive symptoms | ||||
| COVID-19 risk | 0.184 | 0.066 | 2.81 | 0.005 |
| COVID-19 burden | 0.289 | 0.064 | 4.52 | <0.001 |
| Outcome: substance use | ||||
| COVID-19 risk | 0.121 | 0.070 | 1.73 | 0.083 |
| COVID-19 burden | −0.112 | 0.070 | −1.60 | 0.11 |
| Outcome: sleep difficulties | ||||
| COVID-19 risk | 0.244 | 0.065 | 3.73 | <0.001 |
| COVID-19 burden | 0.206 | 0.066 | 3.12 | 0.002 |
Standardized coefficients are presented.